When you are diagnosed with liver cancer and start discussing treatment options, you will often hear an unfamiliar word: embolization. Its full name is transarterial chemoembolization, abbreviated as TACE. It is neither surgery nor a standard chemotherapy infusion but something that sits somewhere in between, which makes it hard to picture at first.
Here is the idea behind it. A tumor in the liver usually draws its blood supply, and therefore its nourishment, from a vessel called the hepatic artery. Embolization threads a thin tube up through that artery, delivers chemotherapy right up to the doorstep of the tumor, and then plugs the entrance of the vessel with tiny particles. The drug becomes concentrated in the tumor, while its supply line is cut off. In effect, the tumor is starved and struck with medicine at the same time. Because the slender catheter is inserted through a vessel in the groin and pushed up to the liver, there is no need to open the abdomen.
So when is it recommended? Usually when there are not just one or two tumors but several scattered through the liver, making them difficult to remove in a single operation, or when the location or number of tumors makes surgery or radiofrequency ablation impractical. The typical candidate has liver function that still holds up reasonably well and no severe spread to other organs. Rather than being a one-and-done procedure, TACE is often repeated several times, with imaging used to judge the response and decide whether another round is needed.
A common experience after treatment is what is called post-embolization syndrome. As the blocked tumor tissue dies off, you may run a fever for a few days, feel a heavy ache in the upper right side of the abdomen, and lose your appetite to nausea. For most people this settles within about a week with pain relief and fluids. It is not a dangerous complication, but knowing about it in advance keeps you from being alarmed.
What you can reasonably expect is for the tumor to shrink or to be held back from growing further. This is less a cure that erases the cancer outright and more a way to slow its progress and keep the liver usable for as long as possible. With some luck, shrinking the tumor with embolization can serve as a stepping stone to a next stage such as surgery or transplantation.
The effect of treatment is checked about a month later with a CT or MRI scan. The team looks at whether the drug stayed well within the tumor and left dead areas behind, and whether any new lesions have appeared. Based on the results, you and your care team will discuss whether to repeat the same treatment or switch to another approach. Since not everything is decided by the outcome of a single embolization, it helps to settle into a calm, long-term frame of mind and follow the course step by step.
This article shares general medical information in plain language and does not replace individual diagnosis or treatment. Please discuss any specific decisions with your own care team.